Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.

被引：0
|
作者：
Ozkan-Dagliyan, Irem [1 ]
Goodwin, Craig M. [1 ]
Bryant, Kirsten L. [1 ]
George, Samuel D. [1 ]
Lucas, Kelly [1 ]
Gautam, Prson [2 ]
Wennerberg, Krister [2 ]
Cox, Adrienne D. [1 ]
Der, Channing J. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Inst Mol Med Finland, Helsinki, Finland
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B31
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [21] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [22] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [23] Genetic modifiers of KRAS-mutant colorectal cancer
    Tjader, Nijole P.
    Ramroop, Johnny
    Gandhi, Tanish
    Campbell, Peter T.
    Chan, Andrew T.
    Gallinger, Steven
    Giles, Graham G.
    Gunter, Marc J.
    Harrison, Tabitha A.
    Hoffmeister, Michael
    Newcomb, Polly A.
    Ogino, Shuji
    Phipps, Amanda I.
    Qu, Conghui
    Schoen, Robert E.
    Pellatt, Andrew
    Woods, Michael O.
    Van Guelpen, Bethany
    Stevens, Patrick
    Hampel, Heather
    Peters, Ulrike
    McElroy, Joseph P.
    Toland, Amanda E.
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [25] Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer
    Alem, Diego
    Yang, Xinrui
    Beato, Francisca
    Sarcar, Bhaswati
    Tassielli, Alexandra F.
    Dai, Ruifan
    Hogenson, Tara L.
    Park, Margaret A.
    Jiang, Kun
    Cai, Jianfeng
    Yuan, Yu
    Fernandez-Zapico, Martin E.
    Tan, Aik Choon
    Fleming, Jason B.
    Xie, Hao
    MOLECULAR CARCINOGENESIS, 2023, 62 (07) : 1025 - 1037
  • [26] Metabolomic Approach to Identify Potential Biomarkers in KRAS-Mutant Pancreatic Cancer Cells
    Kim, Boyun
    Jung, Jewon
    BIOMEDICINES, 2024, 12 (04)
  • [27] Targeting KRAS in Pancreatic Cancer
    Cowzer, Darren
    Zameer, Mohammed
    Conroy, Michael
    Kolch, Walter
    Duffy, Austin G.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
  • [28] Targeting KRAS in pancreatic cancer
    Stickler, Sandra
    Rath, Barbara
    Hamilton, Gerhard
    ONCOLOGY RESEARCH, 2024, 32 (05) : 799 - 805
  • [29] RAF/MEK Dependence of KRAS-Mutant Pancreatic Ductal Adenocarcinomas
    Hanrahan, Aphrothiti J.
    Solit, David B.
    CANCER DISCOVERY, 2012, 2 (08) : 666 - 669
  • [30] Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells
    Hara, Toshifumi
    Jones, Matthew F.
    Subramanian, Murugan
    Li, Xiao Ling
    Ou, Oliver
    Zhu, Yuelin
    Yang, Yuan
    Wakefield, Lalage M.
    Hussain, S. Perwez
    Gaedcke, Jochen
    Ried, Thomas
    Luo, Ji
    Caplen, Natasha J.
    Lal, Ashish
    ONCOTARGET, 2014, 5 (17) : 7635 - 7650
12345